Compounds > isoxazoles
Page last updated: 2024-08-21

isoxazoles and win 56291

isoxazoles has been researched along with win 56291 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andries, K; Chapman, MS; Diana, GD; Gong, ZX; Kim, KH; Kremer, MJ; Minor, I; Oliveira, MA; Rossmann, MG; Willingmann, P1
Giranda, VL; Kofron, JA; Kremer, MJ; Kuhn, RJ; Pevear, DC; Rossmann, MG; Zhao, R1
Goddard, WA; Vaidehi, N1
Aguayo, E; Birkus, G; Cihlar, T; Jordan, R; Lee, G; Mello, C; Rodriguez, M1

Other Studies

4 other study(ies) available for isoxazoles and win 56291

ArticleYear
A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.
    Journal of molecular biology, 1993, Mar-05, Volume: 230, Issue:1

    Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Capsid; Conserved Sequence; Drug Design; Isoxazoles; Models, Molecular; Molecular Sequence Data; Pyridazines; Rhinovirus; Sequence Alignment; Serotyping; Structure-Activity Relationship

1993
Human rhinovirus 3 at 3.0 A resolution.
    Structure (London, England : 1993), 1996, Oct-15, Volume: 4, Issue:10

    Topics: Antigens, Viral; Antiviral Agents; Binding Sites; Biological Evolution; Capsid; Computer Simulation; Crystallography; Humans; Isoxazoles; Models, Molecular; Models, Structural; Molecular Conformation; Molecular Sequence Data; Picornaviridae; Poliovirus; Rhinovirus; RNA, Viral; Sequence Analysis, DNA; Species Specificity; Synchrotrons

1996
The pentamer channel stiffening model for drug action on human rhinovirus HRV-1A.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, Mar-18, Volume: 94, Issue:6

    Topics: Antiviral Agents; Capsid; Common Cold; Computer Simulation; Humans; Isoxazoles; Models, Structural; Protein Conformation; Rhinovirus; RNA, Viral; Software; Structure-Activity Relationship

1997
Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Antiviral Agents; Common Cold; Dose-Response Relationship, Drug; HeLa Cells; Humans; In Vitro Techniques; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Piperidines; Pyridazines; Pyrrolidinones; Replicon; Rhinovirus; RNA, Viral; Tubercidin; Valine; Virus Replication

2014